Estimating the cost of epilepsy

Epilepsia

Volumn 40, Issue SUPPL. 8, 1999, Pages 8-13

  Begley, Charles E ^a   Annegers, John F ^a   Lairson, David R ^a   Reynolds, Thomas F ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

EPILEPSY; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; MEDICAL RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SWITZERLAND; UNITED KINGDOM; UNITED STATES;

EID: 0032747846     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00941.x     Document Type: Review

References (8)

1. Medical Economics Data Division. Drug topics red book. Washington, DC: Medical Economics Co., 1996.
2. National Institutes of Health Consensus Development Conference Statement. Surgery for epilepsy. 1990 March 19-21;8:1-20.
3. Cockerell OC, Hart YM, Sander JWAS, Shorvon SD. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res 1994;18:249-60.
4. Begley CE, Annegers JF, Lairson DR, Reynolds TF, Hauser WA. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994;35:1230-43.
5. Commission for the Control of Epilepsy and its Consequences. Economic cost of epilepsy. In: Plan for nationwide action on epilepsy. Vol IV. DHEW Publication no. 78-279. Washington, DC: NIH, 1978:117-48.
6. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a first unprovoked seizure: an extended follow-up. Neurology 1990;40:1163-70.
7. Lewin-ICF. The cost of disorders of the brain. Unpublished report. Washington, DC: National Foundation for Brain Research, 1992.
8. Gessner U, Sagmeister M, Horisberger B. The cost of epilepsy in Switzerland. Int J Health Sci 1993;4:121-8.